20th Aug 2007 12:28
Aortech International PLC20 August 2007 20 August 2007 AorTech International plc ("AorTech" or the "Company") Result of Extraordinary General Meeting AorTech International (AIM:AOR), the biomaterials and medical device developmentcompany, held its Extraordinary General Meeting today at which all resolutionswere passed. - Ends - For further information please contact: AorTech International plc Tel: + 1 801 201 4336Frank Maguire, Chief Executive Evolution Securities Tel: +44 20 7071 4300Bobbie HilliamTim Worlledge Hogarth Partnership Limited Tel: +44 20 7357 9477Melanie Toyne-SewellSarah Richardson Notes to Editors: About AorTech International plc Listed on AIM in London, AorTech International plc wholly owns AorTechBiomaterials based in Melbourne, Australia. AorTech Biomaterials was formed inJuly 1997 to commercialise a range of medical grade polyurethanes for medicalimplants developed by the Commonwealth Scientific and Industrial ResearchOrganisation (CSIRO). AorTech's Elast-Eon technology is the product of a decade of fundamentalresearch into biologically stable materials. Elast-Eon materials are patented,high silicone content, polyurethane copolymers which exhibit unparalleledbiological and mechanical performance. AorTech is firmly focused on the development and refinement of this material forthe medical community, with the aim of providing a wide range of highperformance Elast-Eon materials in a variety of application specificformulations and densities, for use in medical devices. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
AOR.L